Transition from parenteral to oral treprostinil in pulmonary arterial hypertension-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Transition from parenteral to oral treprostinil in pulmonary arterial hypertension

Published:2017-02 Issue:2 Volume:36 Page:193-201
ISSN:1053-2498
Container-title:The Journal of Heart and Lung Transplantation
language:en
Short-container-title:The Journal of Heart and Lung Transplantation

Author:

Chakinala Murali M.,Feldman Jeremy P.,Rischard Franz,Mathier Michael,Broderick Meredith,Leedom Nicole,Laliberte Kevin,White R. James

Publisher

Elsevier BV

Subject

Transplantation,Cardiology and Cardiovascular Medicine,Pulmonary and Respiratory Medicine,Surgery

Reference22 articles.

1. Advances in therapeutic interventions for patients with pulmonary arterial hypertension;Humbert;Circulation,2014

2. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension

3. A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension;Barst;N Engl J Med,1996

4. Exercise improvement and plasma biomarker changes with intravenous treprostinil therapy for pulmonary arterial hypertension: a placebo-controlled trial;Hiremath;J Heart Lung Transplant,2010

5. Subcutaneous treprostinil is well tolerated with infrequent site changes and analgesics;White;Pulm Circ,2013

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Practical management of oral treprostinil in patients with pulmonary arterial hypertension: Lessons from ADAPT, EXPEDITE, and expert consensus;Respiratory Medicine;2024-09

2. Gaps in evidence in the treatment of prevalent patients with pulmonary arterial hypertension at intermediate risk: An expert consensus;Vascular Pharmacology;2024-09

3. Treatment algorithm for pulmonary arterial hypertension;European Respiratory Journal;2024-08-29

4. Direct prostacyclin transition in pediatric patients with pulmonary hypertension;Pulmonary Circulation;2024-04

5. Comparative effectiveness of oral therapies targeting the prostacyclin pathway in pulmonary arterial hypertension: A systematic review and network meta-analysis;Vascular Pharmacology;2024-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3